18
Participants
Start Date
August 13, 2019
Primary Completion Date
September 30, 2027
Study Completion Date
September 30, 2027
Fulvestrant
"Neoadjuvant Treatment (Cycles 1-4): Fulvestrant 500 mg injection in buttocks on Days 1 and 15 of Cycle 1 and Day 1 of Cycles 2-4.~Adjuvant Treatment (Cycles 5 and beyond): Fulvestrant 500 mg injection in buttocks on Day 1 of each cycle.~Study cycle is 28 days."
Abemaciclib
"Neoadjuvant Treatment (Cycles 1-4): Abemaciclib 150 mg by mouth On Days 1-28 of each cycle.~Adjuvant Treatment (Cycles 5 and beyond): On Days 1-28 of each cycle, you will take Abemaciclib 150 mg by mouth on Days 1-28 of each cycle.~Study cycle is 28 days."
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
AstraZeneca
INDUSTRY
Eli Lilly and Company
INDUSTRY
M.D. Anderson Cancer Center
OTHER